Last updated on: 5/13/2008 | Author: ProCon.org

Diana L. Sylvestre, MD Biography

Title:
Assistant Clinical Professor at the University of California, San Francisco
Position:
Pro to the question "Should Marijuana Be a Medical Option?"
Reasoning:

“[M]odest cannabis use may offer symptomatic and virological benefit to some patients undergoing HCV treatment by helping them maintain adherence to the challenging medication regimen.”

European Journal of Gastroenterology & Hepatology, Oct. 2006

Involvement and Affiliations:
  • Assistant Clinical Professor, Department of Medicine, University of California, San Francisco
  • Founder/Executive Director and Principal Investigator, Organization to Achieve Solutions in Substance Abuse (OASIS), 1998-present
  • Volunteer Associate Physician, Berkeley Free Clinic
  • Medical Advisory Board, American Liver Foundation
  • Member, Hepatitis Advisory Council, Hepatitis Foundation International
  • Liaison Officer of the American Society of Addiction Medicine to the American Medical Association Women Physicians Congress
  • Medical Director, Xanthos, Inc., a nonprofit organization providing social service and substance abuse treatment
  • Member, American Society of Addiction Medicine
  • Member, California Society of Addiction Medicine
  • Member, American Medical Association
Education:
  • MD, Harvard Medical School
  • BS, University of Florida
Other:
  • None found
Quoted in:
  1. Is Marijuana an Effective Treatment for the Symptoms of Hepatitis C?